Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alutard SQ Intra-seasonal Updosing in Grass Pollen Allergy
NCT00807547Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Apr 2008
- Primary completion
- Oct 2008
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of alutard-sq in allergic rhinoconjunctivitis (ARC), sponsored by ALK-Abelló. Started Apr 2008; status: completed.
02
Drugs
alutard-sq
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT00807547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00807547.